Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 5
1964 4
1965 1
1966 4
1967 6
1968 6
1969 14
1970 16
1971 15
1972 15
1973 21
1974 19
1975 14
1976 19
1977 25
1978 22
1979 27
1980 25
1981 24
1982 20
1983 35
1984 83
1985 52
1986 43
1987 64
1988 115
1989 139
1990 159
1991 130
1992 193
1993 150
1994 147
1995 163
1996 150
1997 181
1998 150
1999 163
2000 210
2001 169
2002 222
2003 217
2004 197
2005 235
2006 215
2007 238
2008 258
2009 215
2010 225
2011 248
2012 281
2013 313
2014 306
2015 363
2016 352
2017 313
2018 355
2019 266
2020 339
2021 345
2022 378
2023 300
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

8,300 results

Results by year

Filters applied: . Clear all
Page 1
Bladder Cancer: Current Challenges and Future Directions.
Dobruch J, Oszczudłowski M. Dobruch J, et al. Medicina (Kaunas). 2021 Jul 24;57(8):749. doi: 10.3390/medicina57080749. Medicina (Kaunas). 2021. PMID: 34440955 Free PMC article. Review.
Bladder cancer (BCa) is the most common malignancy of the urinary tract and one of the most prevalent cancers worldwide. ...Finally, improvements in molecular biology and our understanding of tumorigenesis open the era of personalized medicine in bladder canc …
Bladder cancer (BCa) is the most common malignancy of the urinary tract and one of the most prevalent cancers worldwide. ...Fi …
Current best practice for bladder cancer: a narrative review of diagnostics and treatments.
Compérat E, Amin MB, Cathomas R, Choudhury A, De Santis M, Kamat A, Stenzl A, Thoeny HC, Witjes JA. Compérat E, et al. Lancet. 2022 Nov 12;400(10364):1712-1721. doi: 10.1016/S0140-6736(22)01188-6. Epub 2022 Sep 26. Lancet. 2022. PMID: 36174585 Review.
We discuss the current role of radiotherapy, surgical management of non-muscle-invasive and muscle-invasive disease, highlight the challenges of treatment of metastatic bladder cancer, and discuss the latest developments in systemic therapy. This Seminar is intended to pro …
We discuss the current role of radiotherapy, surgical management of non-muscle-invasive and muscle-invasive disease, highlight the challenge …
Diagnosis and Staging of Bladder Cancer.
Ahmadi H, Duddalwar V, Daneshmand S. Ahmadi H, et al. Hematol Oncol Clin North Am. 2021 Jun;35(3):531-541. doi: 10.1016/j.hoc.2021.02.004. Epub 2021 Apr 15. Hematol Oncol Clin North Am. 2021. PMID: 33958149 Review.
Cystoscopic examination remains the gold standard technique for initial diagnosis of bladder cancer (BCa). Despite significant progress in enhanced cystoscopic techniques, blue light cystoscopy and narrow band imaging are the only ones well supported by high-level evidence …
Cystoscopic examination remains the gold standard technique for initial diagnosis of bladder cancer (BCa). Despite significant progre …
Bladder cancer: epidemiology, staging and grading, and diagnosis.
Kirkali Z, Chan T, Manoharan M, Algaba F, Busch C, Cheng L, Kiemeney L, Kriegmair M, Montironi R, Murphy WM, Sesterhenn IA, Tachibana M, Weider J. Kirkali Z, et al. Urology. 2005 Dec;66(6 Suppl 1):4-34. doi: 10.1016/j.urology.2005.07.062. Urology. 2005. PMID: 16399414 Review.
Bladder cancer is a heterogeneous disease with a variable natural history. ...Current studies do not support the routine screening for bladder cancer. However, prospective long-term studies are required to evaluate the benefits of bladder cancer screening, pa …
Bladder cancer is a heterogeneous disease with a variable natural history. ...Current studies do not support the routine screening fo …
Bladder cancer genomics.
Siracusano S, Rizzetto R, Porcaro AB. Siracusano S, et al. Urologia. 2020 May;87(2):49-56. doi: 10.1177/0391560319899011. Epub 2020 Jan 16. Urologia. 2020. PMID: 31942831 Review.
Until recently, the treatment of bladder cancer, for several years, was limited to surgery and to immunotherapy or chemotherapy. ...A future goal will be to combine treatment strategies of invasive bladder cancers according to their genetic mutational load defined b …
Until recently, the treatment of bladder cancer, for several years, was limited to surgery and to immunotherapy or chemotherapy. ...A …
Application of nanotechnology in the diagnosis and treatment of bladder cancer.
Xu Y, Luo C, Wang J, Chen L, Chen J, Chen T, Zeng Q. Xu Y, et al. J Nanobiotechnology. 2021 Nov 27;19(1):393. doi: 10.1186/s12951-021-01104-y. J Nanobiotechnology. 2021. PMID: 34838048 Free PMC article. Review.
For example, gold nanoparticles (AuNPs) have been developed for simple, fast and sensitive urinary sample test for bladder cancer diagnosis. Nanoparticles targeting bladder cancers can facilitate to distinguish the normal and abnormal bladder tissues d …
For example, gold nanoparticles (AuNPs) have been developed for simple, fast and sensitive urinary sample test for bladder can …
Bladder cancer: Present and future.
Martinez Rodriguez RH, Buisan Rueda O, Ibarz L. Martinez Rodriguez RH, et al. Med Clin (Barc). 2017 Nov 22;149(10):449-455. doi: 10.1016/j.medcli.2017.06.009. Epub 2017 Jul 21. Med Clin (Barc). 2017. PMID: 28736063 Review. English, Spanish.
Bladder cancer has a high incidence and involves high associated morbidity and mortality. ...
Bladder cancer has a high incidence and involves high associated morbidity and mortality. ...
Metastatic urothelial carcinoma.
Knowles M, Dyrskjøt L, Heath EI, Bellmunt J, Siefker-Radtke AO. Knowles M, et al. Cancer Cell. 2021 May 10;39(5):583-585. doi: 10.1016/j.ccell.2021.04.012. Cancer Cell. 2021. PMID: 33974855 Free article. Review.
Spectrum of malignant renal and urinary bladder tumors on 18F-FDG PET/CT: a pictorial essay.
Makis W, Ciarallo A, Rakheja R, Probst S, Hickeson M, Rush C, Novales-Diaz JA, Derbekyan V, Stern J, Lisbona R. Makis W, et al. Clin Imaging. 2012 Nov-Dec;36(6):660-73. doi: 10.1016/j.clinimag.2012.01.010. Epub 2012 Jun 8. Clin Imaging. 2012. PMID: 23153993 Review.
A wide variety of malignant renal and urinary bladder diseases can be detected on (18)F-FDG PET/CT. Although the PET/CT findings are often nonspecific, the aim of this atlas was to demonstrate that the spectrum of renal and urinary bladder malig …
A wide variety of malignant renal and urinary bladder diseases can be detected on (18)F-FDG PET/CT. Although the PET/CT …
Bladder cancer.
Morgan TM, Keegan KA, Clark PE. Morgan TM, et al. Curr Opin Oncol. 2011 May;23(3):275-82. doi: 10.1097/CCO.0b013e3283446a11. Curr Opin Oncol. 2011. PMID: 21311329 Review.
PURPOSE OF REVIEW: To review the epidemiology, diagnosis, and management of all stages of bladder cancer with an emphasis on studies published within the last year. RECENT FINDINGS: Smoking continues to be the most important risk factor for the development of bladder …
PURPOSE OF REVIEW: To review the epidemiology, diagnosis, and management of all stages of bladder cancer with an emphasis on studies …
8,300 results